Sohrab Shah

Researcher
  • BC Cancer Research Institute
  • University of British Columbia
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Rare Cancers

    New vistas on cancer biology and treatment: conceptual advancements from the forme fruste project

    A team of Vancouver-based scientists is set to continue its groundbreaking research into rare tumours after receiving renewal funding from the Terry Fox Research Institute. The team led by Dr. David H...

    Read More
  • Completed
    Blood Cancers

    Overcoming treatment failure in lymphoid cancers

    TFRI’s prolific lymphoid cancer team began their research with a simple question: “Why do two-thirds of lymphoma patients recover, while the remainder does not?” A decade later their...

    Read More
  • Completed
    Rare Cancers

    Genomics of forme fruste tumours: new vistas on cancer biology and treatment

    Studying “rare and unusual” forme fruste tumours may not seem like the most obvious way to advance cancer research, but pathologist Dr. David Huntsman’s work is revolutionizing the w...

    Read More
  • Completed
    Blood Cancers

    Molecular correlates of treatment failure in lymphoid cancers

    BC Cancer Agency investigator and TFRI-funded researcher Dr. Randy Gascoyne, research director at the BC Cancer Agency’s Centre for Lymphoid Cancer (CLC), talks about his work in lymphoma, the f...

    Read More
  • Completed
    Ovarian Cancer

    Are genomic instability and clonal diversity prognostic indicators of high grade serous ovarian cancer?

    Dr. Shah is an assistant professor at the University of British Columbia and a scientist with the BC Cancer Agency in Vancouver. He is studying the question of whether instability and diversity in ova...

    Read More

Related News & Events

  • Research Highlight|May 10, 2018

    TFRI-funded researchers uncover “evolutionary arms race” between cancer and immune system

    A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, ...

  • Research Highlight|September 06, 2017

    Discovery of seven new ovarian cancer subtypes opens door for more targeted treatments

    The discovery of seven new genetic subtypes of ovarian cancer may lead to targeted treatments for women diagnosed with this disease, including those w...

  • Research Highlight|September 29, 2016

    Ovarian cancer: Mapping the clonal spread

    A team of B.C.-based, TFRI-funded scientists are breaking new ground with a recent study that tracked the clonal spread and intraperitoneal mixing of ...

  • All News & Events